Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome

Shi-hui Lin; Yi-si Zhao; Dai-xing Zhou; Fa-chun Zhou; Fang Xu

doi:10.1016/j.gendis.2020.06.009

您当前的位置：

首页 >

文章列表页 >

Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome

更新时间：2022-06-24

- Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome
- Genes & Diseases Vol. 7, Issue 4, (2020)
- 作者机构：
  
  1. Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China
  2. Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2020.06.009
  CLC：
- Published：2020，
  
  Published Online：1 December 2020，
扫描看全文
Shi-hui Lin, Yi-si Zhao, Dai-xing Zhou, et al. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. [J]. Genes & Diseases 7(4).(2020)
DOI：

Shi-hui Lin, Yi-si Zhao, Dai-xing Zhou, et al. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. [J]. Genes & Diseases 7(4).(2020) DOI： 10.1016/j.gendis.2020.06.009.

摘要

Abstract

Coronavirus Disease 2019 (COVID-19) was first identified in China at the end of 2019. Acute respiratory distress syndrome (ARDS) represents the most common and serious complication of COVID-19. Cytokine storms are a pathophysiological feature of COVID-19 and play an important role in distinguishing hyper-inflammatory subphenotypes of ARDS. Accordingly

in this review

we focus on hyper-inflammatory host responses in ARDS that play a critical role in the differentiated development of COVID-19. Furthermore

we discuss inflammation-related indicators that have the potential to identify hyper-inflammatory subphenotypes of COVID-19

especially for those with a high risk of ARDS. Finally

we explore the possibility of improving the quality of monitoring and treatment of COVID-19 patients and in reducing the incidence of critical illness and mortality via better distinguishing hyper- and hypo-inflammatory subphenotypes of COVID-19.

关键词

Keywords

Acute respiratory distress syndromeCOVID-19Cytokine stormHyper-inflammatory host responseSARS-Cov-2

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment

Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination

Pandemic COVID-19: Current status and challenges of antiviral therapies

The clinical and immunological features of pediatric COVID-19 patients in China

Related Author

Sunny Kumar

Malini Basu

Pratyasha Ghosh

Uttam Pal

Mrinal K. Ghosh

Qianqian Zhou

Yanhua Chen

Ruolei Wang

Related Institution

Department of Microbiology, Dhruba Chand Halder College, Dakshin Barasat, West Bengal

Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector–V, Salt Lake, Kolkata-700091 & 4, Raja S.C. Mullick Road, Jadavpur, Kolkata

Department of Economics, Bethune College, University of Calcutta, Kolkata

Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine

State Key Laboratory of Agricultural Microbiology, College of Fisheries, Huazhong Agricultural University

⁰